The receptor ligand rimcazole alters secretion of prolactin and -melanocyte stimulating hormone by dopaminergic and non-dopaminergic mechanisms

Author： Eaton M.J.   Lookingland K.J.   Moore K.E.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.299, Iss.1, 1996-03, pp. : 171-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-dopaminergic drug treatment of Parkinson’s disease

By Müller T.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 4, 2001-04 ,pp. : 557-572

Informa Healthcare

Access to resources Recommend Favorite

Selective properties of C- and N-terminals and core residues of the melanocyte-stimulating hormone on binding to the human melanocortin receptor subtypes

By Schioth H.B.   Mutulis F.   Muceniece R.   Prusis P.   Wikberg J.E.S.  

European Journal of Pharmacology, Vol. 349, Iss. 2, 1998-05 ,pp. : 359-366

Elsevier

Access to resources Recommend Favorite

Kinetic analysis of GM 1 effects on haloperidol-induced dopaminergic supersensitivity - elementary considerations of ligand-receptor interations

By Palermo-Neto J.   Frussa-Filho R.   Vital M.A.B.F.  

General Pharmacology, Vol. 32, Iss. 2, 1999-02 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite

Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System

By  

Current Medicinal Chemistry, Vol. 23, Iss. 9, 2016-03 ,pp. : 874-883

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of nicotine on sniffing induced by dopaminergic receptor stimulation

By Zarrindast M.-R.   Mohaddess G.   Rezvani-Pour M.  

European Neuropsychopharmacology, Vol. 10, Iss. 5, 2000-09 ,pp. : 397-400

Elsevier

Access to resources Recommend Favorite